Efficacy of A Mydriatic Mixture of 0.5% Tropicamide and 5% Phenylephrine at Thammasat University Hospital

  • Nattapon Wongcumchang Department of Ophthalmology, Faculty of Medicine, Thammasat University, Rangsit Campus, Pathumthani, 12120, Thailand
  • Tarawadee Chawarung Department of Ophthalmology, Faculty of Medicine, Thammasat University, Rangsit Campus, Pathumthani, 12120, Thailand
Keywords: Mydriatics, Phenylephrine, Tropicamide, Pupillary dilatation


Purpose: To compare the effectiveness of mydriasis between mydriatic mixtures of 0.5% tropicamide and 5% phenylephrine versus 1% tropicamide and 10% phenylephrine.

Design: Prospective randomized controlled trial

Methods: In this study, 30 Asian patients with dark irides were randomized to receive topical 1% tropicamide and 10% phenylephrine (conventional regimen), and 30 patients to receive a
fixed combination of 0.5% tropicamide and 5% phenylephrine (mixed regimen). The vertical pupillary dilatation, blood pressure, and pulses were studied.

Results: Sixty patients were equally randomized into conventional and mixed regimens. For the conventional and mixed regimen groups; the mean baseline pupil diameter was 1.49 ± 0.62
mm and 1.84 ± 0.64 mm, respectively. The mean pupil diameter at 15 minutes was statistically significant difference between both groups, 3.79 ± 0.90 mm in the conventional regimen group and 4.30 ± 1.05 mm in the mixed regimen group with mean difference 0.5133 mm (95%CI 0.0076 - 1.0191, P = 0.047). Whereas the mean pupil diameter at 30, 45, and 60 minutes showed no significant difference between groups. In the first 30 minutes, the proportion of eyes that achieved 7 mm pupil size between both groups was significant difference, 36.7% in the conventional regimen group, and 63.3% mixed regimen group (P = 0.039). At 60 minutes, the proportion was 86.7% and 96.7% respectively (P = 0.353). There was no significant difference in arterial blood pressure and pulse rate between groups.

Conclusion: The mixture of 0.5% tropicamide and 5% phenylephrine showed comparable efficacy to a conventional regimen and resulted in greater pupillary dilatation within the first 15 minutes,
allowing for more rapid achievement of desired mydriasis.




Download data is not yet available.


1. Krumholz DM, Portello JK, Rosenfield M, Rosenbaum JD. A combination solution for routine pupillary dilatation. Optometry. 2006;77:350-353.
2. Rengstorff RH, Doughty CB. Mydriatic and cycloplegic drugs: a review of ocular and systemic complications. Am J Optom Physiol Opt. 1982;59:162-177.
3. Obianwu HO, Rand MJ. The relationship between the mydriatic action of ephredine and the colour of the iris. The British Journal of Ophthalmology. 1965;49(5):264–270.
4. Yospaiboon Y, Luanratanakorn P, Noppawinyoowong C. Randomized double-blind study of phenylephrine 2.5% vs 10% on pupillary dilation. Journal of the Medical Association of Thailand. 2004:1380-1384.
5. Trinavarat A, Pituksung A. Effective pupil dilatation with a mixture of 0.75% tropicamide and 2.5% phenylephrine: A randomized controlled trial. Indian J Ophthalmol. 2009;57:351-354.
6. Bartlett DK. Dilatation of the pupil. In: Bartlett JD, Jaanus SD. Clinical Ocular Pharmacology. 4th ed. Boston: Butterworth-Heinmann;2001:405-411.
7. Alcon Canada Inc. Mydriacyl: prescribing information and consumer information. Canada: Alcon; 2018 May. https://www.alcon.ca/sites/www.alcon.ca/files/Mydriacyl-PM-16-May-2018-e.pdf.Accessed April 16, 2019.
8. Bhurayanontachai P, Saengkaew S, Apiromruck P. Efficacy of an eye drop mixture for pupillary dilatation: A randomized comparative study. Journal of Optometry. 2017;10(2):111-116.
9. Yamazaki T, Shimada Y, Taenaka N, Oshumi H, Takezawa J, Yoshiya I. Circulatory responses to after loading with phenylephrine in hyperdynamic sepsis. Crit. Care Med. Jul 1982;10(7):432-435.
Original Articles